Skip to content
杏國新藥股份有限公司 Logo 杏國新藥股份有限公司 Logo 杏國新藥股份有限公司 Logo
  • About Us
    • Management
    • History
  • Our Focus Area
    • Innovative Drugs
      • Pipelines
      • SB01&02
      • SB03
      • SB04
      • SB05
    • Ophthalmic Diagnostic Device
      • History
      • FloM-S
      • epiCam C
      • epiCam M
      • epiCam V
    • Product Information
      • Pharmaceutical
        • Veregen®
  • Media
    • News
    • Events
    • Knowledge
  • Investors
    • Shareholder Information
      • Shareholder Structure
      • Shareholder Meeting
  • Partnering
  • Contact Us
  • enEnglish
    • zh-hant繁體中文
  • About Us
    • Management
    • History
  • Our Focus Area
    • Innovative Drugs
      • Pipelines
      • SB01&02
      • SB03
      • SB04
      • SB05
    • Ophthalmic Diagnostic Device
      • History
      • FloM-S
      • epiCam C
      • epiCam M
      • epiCam V
    • Product Information
      • Pharmaceutical
        • Veregen®
  • Media
    • News
    • Events
    • Knowledge
  • Investors
    • Shareholder Information
      • Shareholder Structure
      • Shareholder Meeting
  • Partnering
  • Contact Us
  • enEnglish
    • zh-hant繁體中文
  • About Us
    • Management
    • History
  • Our Focus Area
    • Innovative Drugs
      • Pipelines
      • SB01&02
      • SB03
      • SB04
      • SB05
    • Ophthalmic Diagnostic Device
      • History
      • FloM-S
      • epiCam C
      • epiCam M
      • epiCam V
    • Product Information
      • Pharmaceutical
        • Veregen®
  • Media
    • News
    • Events
    • Knowledge
  • Investors
    • Shareholder Information
      • Shareholder Structure
      • Shareholder Meeting
  • Partnering
  • Contact Us
  • enEnglish
    • zh-hant繁體中文
Home/2020/May

SynCore Biotechnology to attend the 2020 BIO International Convention

SynCore Biotechnology (SynCore Bio) is pleased to announce that [...]

Merissa2020-05-20T14:42:38+08:00May 20th, 2020|Latest Events|
Read More

SB05 Pancreatic Cancer Clinical Trial Reaches Conditions to Conduct Interim Analysis

SynCore’s global phase III clinical trial on pancreatic cancer [...]

Merissa2020-05-25T17:20:18+08:00May 7th, 2020|Press Release|
Read More

Search

Recent Posts

  • Syncore Biotechnology to Participate at the Biotech Showcase 2022 Conference
  • SynCore Biotechnology to attend the 2022 BIO Partnering at JPM
  • SynCore Biotechnology to attend the 2021 BIO Asia-Taiwan Exhibition
  • SynCore Biotechnology to Participate at the BIO-EUROPE Digital –Building Partnerships in a Digital Age. Facilitating the Flow of Global Life Science Deals
  • SynCore Biotechnology to attend the 2021 BIO Asia-Taiwan Online Exhibition

Archives

  • January 2022
  • November 2021
  • October 2021
  • June 2021
  • October 2020
  • August 2020
  • July 2020
  • May 2020
  • July 2019
  • June 2019
  • March 2019
  • January 2019
  • December 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • February 2018
  • November 2017
  • July 2017
  • May 2017
  • April 2017
  • January 2017
  • November 2016
  • December 2015

Categories

  • Latest Events
  • Press Release

Phone: +886-2-2760-3688
Fax: +886-2-2763-9287
Taipei Office:
4F, No.69, DongXing Rd., XinYi Dist., Taipei City 110, Taiwan

About Us

  • Leadership
  • History

Focus Area

  • Innovative Drugs
  • Ophthalmic Diagnostic Device

Media

  • News
  • Events
  • Knowledge

Investor

  • Investors
  • Financial Reports
  • Shareholder Information

Partnering

  • Contact Us
  • Partnering
  • Join Us
Copyright© 2018 杏國新藥股份有限公司 | 網頁設計公司:振作國際